GlassScriptPhysician profile
Francis Collins
NPI 1053354142
$1,690.09
in general payments reported to CMS, 2019-2025
20 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.71 · 2020: $29.99 · 2021: $70.49 · 2022: $13.21 · 2023: $999 · 2024: $370 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,526.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $309.72 | 2020-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Amgen INC. | $212.64 | 2023-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $207.29 | 2022-2024 | Glassia |
| Glaxosmithkline, LLC. | $158.32 | 2020-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Grifols USA, LLC | $138.81 | 2023 | Prolastin-C Liquid, Xembify |
| Mallinckrodt Hospital Products INC. | $128.61 | 2023-2024 | Acthar |
| Jazz Pharmaceuticals INC. | $98.38 | 2023-2024 | |
| Genzyme Corporation | $84.04 | 2023-2024 | |
| Mylan Specialty L.P. | $67.66 | 2023-2024 | Yupelri |
| Pfizer INC. | $63.98 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $44.18 | 2023-2024 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.86 | 2019 | |
| Sunovion Pharmaceuticals INC. | $24.85 | 2019 | |
| Abbvie INC. | $22.55 | 2024 | |
| Gilead Sciences, INC. | $22.07 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.42 | 2025 | Cardiomems |
| Insmed, INC. | $17.08 | 2024 | Arikayce |
| Baxter Healthcare | $15.88 | 2023 | Hillrom - Life 2000 Ventilation System |
| Paratek Pharmaceuticals, INC. | $13.98 | 2023 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $13.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.